Greg Erman is President & CEO of EmpiraMed, Inc., a digital health company that runs prospective Virtual Clinical Studies to generate Real World Evidence for the Life Science Industry. Formed in 2011 and sitting at the intersection of DCT (Decentralized Clinical Trials) and RWE, EmpiraMed pioneered the technology and methods of 100% site-less virtual trials. Greg’s career centers on entrepreneurship, intellectual property research commercialization, and business leadership. As the first Entrepreneur-in-Residence at Partners HealthCare (now Mass General Brigham), he collaborated on over 250 life science research projects within a 10 year period. Greg raised about $100M in venture capital and successfully grew businesses to about $20M in annual revenue with 150 employees. As the founder and CEO of 6 companies, each of his 3 VC-backed startups exited to large public companies while generating returns of up to 12X investment. The businesses Greg built are diverse and cut across many industries in the fields of biotech, medical devices, and digital health. He holds BSEE and Marketing MBA degrees with high honors from Rutgers University, sits on several biotech and digital health corporate boards of directors, is an angel investor, and is a part-time paid entrepreneurship lecturer at Harvard Medical School. Greg gives back to the community by volunteering as a mentor and judge for Harvard Innovation Labs, MassChallenge, MIT, and MassBio, as well as by serving on the boards of non-profit organizations, such as Life Science Cares and Big Brothers Big Sisters of Eastern Massachusetts. Greg is an avid coastal sailor and racer, jazz trumpeter, and tennis player who deludes himself into thinking there’s still time for his debut at the US Open.